Electric field device takes on pancreatic cancer in new trial
NCT ID NCT07284277
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a wearable device that creates electric fields (TTFields) combined with chemotherapy for people with metastatic pancreatic cancer. The device is worn at home for at least 18 hours a day and aims to disrupt cancer cell division. The trial will check if the combination is safe and if patients can stick with the treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tumor Treating Fields (TTFields) device plus chemotherapy (modFOLFIRINOX)
What this could lead to
If it works, this could offer a new treatment option for metastatic pancreatic cancer by combining a wearable device with standard chemo.
What could go wrong
This is an early-phase trial with only 30 participants, so results may not apply broadly. The device must be worn at least 18 hours daily, which may be burdensome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Fundación Jiménez-Díaz
NOT_YET_RECRUITINGMadrid, 28040, Spain
-
Hospital Universitario de Araba
NOT_YET_RECRUITINGVitoria-Gasteiz, Álava, 01009, Spain
-
Hospital Universitario de Cruces
NOT_YET_RECRUITINGBarakaldo, Vizcaya, 48903, Spain
-
Hospital de Galdakao
NOT_YET_RECRUITINGGaldakao, Vizcaya, 48960, Spain